Inhibition of Gastric Acid Secretion by Jejunal Glucose and Its Relation to Osmolality and Glucose Load

References

• Matsuyama M. Influence of introduction of glucose into the intestine upon the secretion of the gastric juice. Jpn J Gastroenterol 1932; 4: 273–279
   Google Scholar
• Shay H, Gershon-Cohen J, Fels S S, Siplet H. Concerning the influence of glucose on the response of the human stomach to test meals. Am J Dig Dis 1942; 9: 363–367
   Google Scholar
• Sircus W. Studies on the mechanisms in the duodenum inhibiting gastric secretion. Q J Exp Physiol 1958; 43: 114–133
   PubMedGoogle Scholar
• Christiansen J, Hendel L. Inhibition of pentagastrin induced gastric acid secretion in man by intrajejunal glucose administration. Acta Chir Scand 1974; 140: 246–248
   PubMedGoogle Scholar
• Christiansen J, Holst J J, Rokkjaer M. Jejunal inhibition of pentagastrin induced gastric acid secretion in man and Heidenhain pouch dogs. Gastroenterology 1976; 11: 219–224
   Google Scholar
• Konturek S J, Grossman M I. Effect of perfusion of intestinal loops with acid fat or dextrose on gastric secretion. Gastroenterology 1965; 49: 483–489
   Google Scholar
• Petersen B, Christiansen J, Holst J J. A glucose-dependent mechanism in jejunum inhibits gastric acid secretion: a response mediated through entero-glucagon. Scand J Gastroenterol 1985; 20: 193–197
   PubMed Web of Science ®Google Scholar
• Petersen B, Christiansen J, Rokaeus A, Rosell S. Effect of intravenous and intrajejunal fat infusion on gastric acid secretion and plasma neurotensin-like immunoreactivity in man. Scand J Gastroenterol 1984; 19: 48–51
   PubMed Web of Science ®Google Scholar
• Christiansen J, Holst J J, Kalaia E. Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon. Gastroenterology 1976; 70: 688–692
   PubMed Web of Science ®Google Scholar
• Kirkegaard P, Moody A J, Holst J J, Loud F B, Olsen P S, Christiansen J. Glicentin inhibits gastric, acid secretion in the rat. Nature 1982; 297: 156–157
   PubMed Web of Science ®Google Scholar
• Olsen J A, Loud F B, Christiansen J. Inhibition of meal stimulated gastric acid secretion by an octa-peptide analogue SMS 201–995. Gut 1987; 28: 464–467
   PubMedGoogle Scholar
• Pederson R A, Brown J C. Inhibition of histamine-, pentagastrin- and insulin-stimulated canine gastric secretion by pure ‘gastric inhibitory polypeptide’. Gastroenterology 1972; 62: 393–400
   PubMed Web of Science ®Google Scholar
• Petersen B, Christiansen J, Kirkegaard P, Skov Olsen P. The stability of gastric acid secretion during prolonged pentagastrin stimulation in man. Clin Sci 1984; 66: 99–101
   Web of Science ®Google Scholar
• Henriksen F W, Jorgensen S P, Molller S. Interaction between secretin and cholecystokinin on inhihition of gastric secretin in man. Gastroenterology 1974; 9: 735–740
   Google Scholar
• Holst Pedersen J, Stadil F, Fahrenkrug J. Preparation of 125I-(Tyr 3)- and 125I-(Tyr 11)-neurotensin for radioimmunoanalysis. Scand J Clin Lab Invest 1983; 43: 483–491
   PubMedGoogle Scholar
• Holst Pedersen J, Fahrenkrug J. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism. Peptides 1986; 7: 15–20
   PubMedGoogle Scholar
• Theodorsson-Norheim E. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Regul Pept 1983; 6: 207–218
   PubMedGoogle Scholar
• Holst J J, Christiansen J, Kühl C. The entero-glucagon response to intrajejunal infusion of glucose triglycerides and sodium chloride and its relation to jejunal inhibition of gastric acid secretion in man. Scand J Gastroenterol 1976; 11: 297–304
   PubMed Web of Science ®Google Scholar
• Hilsted L, Holst J J. On the accuracy of radio-immunological determination of somatostatin in plasma. Regul Pept 1982; 4: 12–31
   Google Scholar
• Krarup T, Madspad S, Moody A F. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin dependent) diabetics. Clin Endoclinol Metab 1983; 56: 1306–1312
   PubMedGoogle Scholar
• Widdonson G M, Penton J R. Determination of serum and plasma glucose on the ‘out-analyzen II’ by use of hexokinase reaction. Clin Chem 1972; 18: 299–300
   PubMed Web of Science ®Google Scholar
• Bradley J V. Distribution free statistical tests. Prentice-Hall, Englewood Cliffs, NJUS 1968; 138–141
   Google Scholar
• Matsuyama M. The behaviour of sugar towards the secretion of the gastric juice. Jpn J Gastroenterol 1932; 4: 262–272
   Google Scholar
• Dotevall G, Muren A. Effect of intravenous infusion of glucose on gastric secretory response to feeding in Pavlov and Heidenhain-pouch dogs. Acta Physiol Scand 1961; 52: 234–241
   PubMedGoogle Scholar
• Moore J G. Gastric acid suppression by intravenous glucose solutions. Gastroenterology 1973; 64: 1106–1110
   PubMed Web of Science ®Google Scholar
• Solomon S P, Spiro H M. The effects of glucagon and glucose on the human stomach. Am J Dig Dis 1959; 4: 775–786
   PubMedGoogle Scholar
• Holst J J, Christiansen J. The effect of intravenous glucose on pentagastrin-induced gastric acid secretion in man. Acta Chir Scand 1975; 141: 289–291
   PubMedGoogle Scholar
• Ward A S. Effect of vagotomy on the gastric secretory response to intraduodenal osmotic agents in man. Gut 1976; 17: 48–53
   PubMed Web of Science ®Google Scholar
• Christiansen J, Aagaard P, Hansen T. Jejunal inhibition of gastric acid secretion induced by hypertonic glucose in duodenal ulcer patients before and after truncal vagotomy. Ann Surg 1978; 187: 122–125
   PubMed Web of Science ®Google Scholar
• Skov Olsen P, Kirkegaard P, Holst J J, Christiansen J. Vagal control of glucagon-induced inhibition of gastric acid secretion in duodenal ulcer patients. Scand J Gastroenterol 1982; 17: 629–632
   PubMedGoogle Scholar
• Anderson S, Rosell S, Sjodin L, Folkers K. Inhibition of acid secretion in duodenal ulcer patients. Scand J Gastroenterol 1980; 15: 253–256
   PubMedGoogle Scholar
• Olsen P S, Pedersen J H, Kirkegaard P. Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy. Gut 1984; 25: 451–484
   Google Scholar
• Blackburn A M, Bloom S R. Neurotensin and the dumping sundrome. Gut 1978; 19: A477
   Google Scholar
• Holst Pedersen J, Knuthsen S, Bernabei M, ørskov C, Holst J J. Secretion of neurotensin from isolated perfused porcine ileum. Regul Pept 1988; 21: 13–19
   PubMedGoogle Scholar
• Lee Y C, Allen J M, Uttenthal L P. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization. J Clin Endocrinol Metab 1984; 59: 45–50
   PubMed Web of Science ®Google Scholar
• Holst Pedersen J, Andersen Hø, Olsen P S. Pharmacokinetics and metabolism of neurotensin in man. J Clin Endocrinol Metab
   Google Scholar
• Pedersen Holst J, Olsen Skov P, Kirkegaard P, Fahrenkrug J, Stadil F. Effect of neurotensin and neurotensin fragments on gastric acid secretion in man. Regul Pept 1986; 15: 77–86
   PubMedGoogle Scholar
• Matsuyama T, Tanaka R, Shima K, Tarui S. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose. Horm Metab Res 1979; 11: 214–216
   PubMedGoogle Scholar
• Dubrasquet M, Bataille D, Gespach C. Fourth international symposium on gastrointestinal hormones. AB Exelsior, Stockholm 1982; 56
   Google Scholar
• Kirkegaard P, Moody A J, Holst J J, Loud F B, Skov Olsen P, Christiansen J. Glicentin inhibits gastric acid secretion in the rat. Nature 1982; 297: 156–157
   PubMed Web of Science ®Google Scholar
• Crockett S E, Cataland S, Falko J, Mazzaferri E L. Gastric inhibitory polypeptide: responses to variable doses of glucose in normal subjects and abnormal responses to oral glucose in patients with adult onset diabetes mellitus. Diabetes 1975; 24(suppl 2)413
   Google Scholar
• Brown J C. Gastric inhibitory polypeptide. Springer-Verlag, Berlin 1982; 20–22
   Google Scholar
• Olsen J, Mortensen P E, Sheik S, Jacoby N, Christiansen J. Does polypeptide YY take part in the physiological regulation of gastric acid secretion in man?. Digestion
   Google Scholar
• Adrian T, Savage A, Sager G, et al. Effect of peptide YY on gastric, pancreatic and biliary function in humans. Gastroenterology 1985; 89: 494–499
   PubMed Web of Science ®Google Scholar